Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Polypoidal Choroidal Vasculopathy”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07365371
What this trial is testing

A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Polypoidal Choroidal Vasculopathy (PCV)Neovascular Age Related Macular Degeneration (AMD)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 174
Post-approval studies (Phase 4)UnknownNCT02681783
What this trial is testing

PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLibercept

Who this might be right for
Central Serous ChorioretinopathyAge Related Macular DegenerationIdiopathic Poplypoidal Choroidal Vasculopathy
Sunnybrook Health Sciences Centre 90
Testing effectiveness (Phase 2)UnknownNCT03594461
What this trial is testing

Intense Treatment Regimen With Intravitreal Aflibercept Injection

Who this might be right for
Neovascular Age-Related Macular Degeneration
Vitreous -Retina- Macula Consultants of New York 30
Post-approval studies (Phase 4)UnknownNCT02092532
What this trial is testing

Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial)

Who this might be right for
Neovascular Polypoidal Choroidal Vasculopathy
Southeast Retina Center, Georgia 20
Post-approval studies (Phase 4)Study completedNCT02120950
What this trial is testing

Aflibercept in Polypoidal Choroidal Vasculopathy

Who this might be right for
Neovascular Macular Degeneration
Bayer 333
Large-scale testing (Phase 3)Study completedNCT05666804
What this trial is testing

Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy

Who this might be right for
Macular Polypoidal Choroidal Vasculopathy (PCV)
Novartis Pharmaceuticals 148
Not applicableUnknownNCT03128463
What this trial is testing

Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases

Who this might be right for
Age-Related Macular DegenerationPolypoidal Choroidal VasculopathyPathological Myopia+2 more
Xun Xu 5,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT06550011
What this trial is testing

Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravitreal (IVT) Injection of ABI-110 (AAV2.N54-VEGF Trap) in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (wAMD), Including Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Neovascular (Wet) AMD
Avirmax Biopharma Inc 18